LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Havard's Nursing Guide to Drugs
- 11th Edition - October 18, 2021
- Author: Adriana Tiziani
- Language: English
- Paperback ISBN:9 7 8 - 0 - 7 2 9 5 - 4 3 5 9 - 0
- eBook ISBN:9 7 8 - 0 - 7 2 9 5 - 8 8 2 8 - 7
- eBook ISBN:9 7 8 - 0 - 7 2 9 5 - 8 8 2 9 - 4
Trusted by nursing and midwifery students and clinicians in Australia since 1983, the 11th edition of Havard’s Nursing Guide to Drugs is an indispensable tool for reliable, accura… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteTrusted by nursing and midwifery students and clinicians in Australia since 1983, the 11th edition of Havard’s Nursing Guide to Drugs is an indispensable tool for reliable, accurate and up-to-date drug information.
The guide is easy to access and user-friendly. It provides all the medication information you need to know, with drugs classified by both therapeutic class and body system, and referred to by both trade and generic name. The book includes best practice in drug administration as well as patient teaching information to improve care.
This edition has been comprehensively reviewed and updated to ensure that usage, dose, side effects, contraindications and precautions are consistent with current Australian pharmaceutical guidelines.
- Available forms, action, use, dosage, adverse effects and interactions
- Formulae to calculate drug doses and drip rates
- All drugs listed by therapeutic class and body system
- Nursing points, including administration advice and cautions
- Patient education notes
- Midwifery/pregnancy considerations
- An eBook included in all print purchases
- Cover image
- Title page
- Table of Contents
- Inside front cover
- Copyright
- Dedication
- Contents by body system
- Introduction
- Reviewers
- Acne treatment
- TOPICAL AGENTS USED IN ACNE MANAGEMENT
- Analgesics and non-steroidal anti-inflammatory drugs (NSAIDs)
- Anorectics and weight-loss agents
- Anthelmintics
- Anti-Alzheimer’s agents
- Antianginal agents
- Antianxiety agents
- Antiarrhythmic agents
- CLASS I
- CLASS IA
- CLASS IB
- CLASS IC
- CLASS II
- CLASS III
- CLASS IV
- ATYPICAL ANTIARRHYTHMIC AGENTS
- Antiasthma agents, bronchodilators and respiratory agents
- BRONCHODILATORS (BETA-2 ADRENOCEPTOR AGONISTS (ALSO CALLED BETA-2 AGONISTS))
- ANTICHOLINERGIC (ANTIMUSCARINIC) AGENTS
- XANTHINES
- PROPHYLACTIC AND ANTI-INFLAMMATORY DRUGS
- MAST CELL STABILISERS
- CORTICOSTEROIDS
- LEUKOTRIENE RECEPTOR ANTAGONISTS
- OTHER RESPIRATORY AGENTS
- Antibacterial agents
- INHIBITORS OF BACTERIAL CELL WALL SYNTHESIS
- PENICILLINS
- CEPHALOSPORINS
- MONOBACTAMS AND CARBAPENEMS
- GLYCOPEPTIDES
- INHIBITORS OF BACTERIAL PROTEIN SYNTHESIS
- AMINOGLYCOSIDES
- TETRACYCLINES
- MACROLIDES
- LINCOSAMIDES
- OTHER MISCELLANEOUS INHIBITORS OF BACTERIAL PROTEIN SYNTHESIS
- INHIBITORS OF DNA SYNTHESIS
- QUINOLONES (ALSO KNOWN AS FLUOROQUINOLONES)
- DISRUPTING BACTERIAL CELL MEMBRANE
- OTHER ANTIBACTERIAL AGENTS
- Anticoagulants and antithrombotic agents
- HEPARIN and LOW MOLECULAR WEIGHT HEPARINS (LMWHs)
- LOW MOLECULAR WEIGHT HEPARINS
- VITAMIN K ANTAGONISTS
- ANTITHROMBIN III-DEPENDENT ANTICOAGULANTS
- DIRECT THROMBIN INHIBITORS
- DIRECT FACTOR XA INHIBITORS
- OTHER THROMBOTIC AGENTS
- Antidepressants
- TRICYCLIC and RELATED ANTIDEPRESSANTS (TCAs)
- MONOAMINE OXIDASE INHIBITORS (MAOIs)
- REVERSIBLE INHIBITORS of MONOAMINE OXIDASE TYPE a (RIMAs)
- SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)
- SEROTONIN and NORADRENALINE REUPTAKE INHIBITORS (SNRIs)
- ATYPICAL ANTIDEPRESSANT AGENTS
- Antidiabetic agents
- INSULINS
- ORAL HYPOGLYCAEMIC AGENTS
- SULFONYLUREAS
- BIGUANIDES
- ALPHA GLUCOSIDASE INHIBITORS
- THIAZOLIDINEDIONES
- DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS
- GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUES
- SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS (SGLT2 INHIBITORS)
- Antidiarrhoeal agents
- Antidotes, antagonists and chelating agents
- Antiemetic agents
- 5HT3 RECEPTOR ANTAGONISTS
- NEUROKININ-1 (NK1) RECEPTOR ANTAGONISTS
- DOPAMINE ANTAGONISTS
- OTHER ANTIEMETIC AGENTS
- Antiepileptics
- Antifungal agents
- Antiglaucoma agents
- Antigout and uricolytic agents
- Antihistamines
- Antihypertensive agents
- ALPHA-ADRENOCEPTOR BLOCKING AGENTS
- ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS
- ANGIOTENSIN II RECEPTOR ANTAGONISTS
- BETA-ADRENOCEPTOR BLOCKING AGENTS
- CALCIUM-CHANNEL BLOCKERS
- CENTRALLY ACTING AGENTS
- DIRECT ACTING VASODILATORS
- Antimalarial agents
- Antimigraine agents
- Antimycobacterial agents
- Antineoplastic agents
- Antineoplastic support agents
- GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF)
- Anti-Parkinson’s agents
- ANTICHOLINERGIC ANTI-PARKINSON’S AGENTS
- CATECHOL-O-METHYL TRANSFERASE (COMT) INHIBITORS
- DOPAMINE AGONISTS
- MONOAMINE OXIDASE TYPE B ENZYME (MAO-B) INHIBITORS
- Antiplatelet agents
- Antiprotozoal agents
- Antipsychotic and mood-stabilising agents
- Antiulcer agents
- HISTAMINE H2-RECEPTOR ANTAGONISTS
- PROTON PUMP INHIBITORS
- CYTOPROTECTIVE AGENTS
- ANTACIDS
- Antiviral agents
- ANTIVIRAL (NON-RETROVIRAL) AGENTS
- DNA POLYMERASE INHIBITORS
- NEURAMINIDASE INHIBITORS
- NS3/4A PROTEASE INHIBITORS
- NS5A INHIBITORS
- NS5B RNA-DEPENDENT RNA PROTEASE INHIBITORS
- OTHER ANTIVIRAL AGENTS
- ANTIRETROVIRAL AGENTS
- NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTIs)
- NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NNRTIs)
- PROTEASE INHIBITORS (PI)
- ENTRY INHIBITORS
- INTEGRASE INHIBITORS
- Bladder function disorder agents
- Bone and calcium regulating agents
- BISPHOSPHONATES
- OTHER BONE and CALCIUM REGULATING AGENTS
- Cardiac glycosides
- Cholinergic and anticholinergic agents
- CHOLINERGIC (PARASYMPATHOMIMETIC) AGENTS
- ANTICHOLINERGIC AGENTS
- Corticosteroids
- Cough suppressants and expectorants
- Dermatological agents
- TOPICAL ECTOPARASITICAL AGENTS
- PEDICULOSIS (LICE INFESTATION)
- SCABIES
- OTHER DERMATOLOGICAL PREPARATIONS
- Disease-modifying antirheumatic drugs (DMARDs)
- CONVENTIONAL DMARDs
- TUMOUR NECROSIS FACTOR ALPHA (TNF-α) ANTAGONISTS
- CYTOKINE MODULATORS
- Diuretics
- CARBONIC ANHYDRASE INHIBITORS
- LOOP DIURETICS
- THIAZIDE DIURETICS
- POTASSIUM-SPARING DIURETICS
- OSMOTIC DIURETICS
- Drug dependence
- Erectile dysfunction agents
- INTRACAVERNOSAL ADMINISTRATION
- PHOSPHODIESTERASE TYPE 5 (PDE5) INHIBITORS
- OTHER AGENTS
- Eye, ear, nose and throat agents
- THE EYE
- CYCLOPLEGIC AND MYDRIATIC DROPS
- MIOTICS AND OCULAR DECONGESTANTS
- AGENTS USED FOR MACULAR DEGENERATION
- OTHER OPHTHALMIC AGENTS
- THE EAR
- WAX SOFTENERS
- THE NOSE
- SYMPATHOMIMETIC NASAL DECONGESTANTS
- THE OROPHARYNX
- ANTI-INFECTIVE AGENTS
- Fibrinolytic agents
- Gastrointestinal agents (miscellaneous)
- AGENTS USED IN INFLAMMATORY BOWEL DISEASE
- ENZYME REPLACEMENT
- General anaesthetics
- NITROUS OXIDE
- Haemopoietic agents
- Haemostatics
- COAGULATION FACTORS
- Hypothalamic and pituitary hormones
- GONADOTROPHIN-RELEASING HORMONE
- GROWTH HORMONE RELEASE-INHIBITING FACTOR
- ANTERIOR PITUITARY HORMONES
- GROWTH HORMONE (SOMATOTROPIC HORMONES)
- PROLACTIN SUPPRESSION
- POSTERIOR PITUITARY HORMONES
- ANTIDIURETIC HORMONE (ADH)
- Immunomodifiers
- INTERFERONS
- Laxatives
- BULK-FORMING LAXATIVES
- OSMOTIC LAXATIVES
- STIMULANT LAXATIVES
- FAECAL SOFTENERS
- OTHER AGENTS
- Lipid regulating agents
- HMG-CoA REDUCTASE INHIBITORS (STATINS)
- BILE ACID BINDING AGENTS
- FIBRATES
- PCSK9 INHIBITORS
- OTHER LIPID-LOWERING AGENTS
- Local anaesthetics
- LOCAL ANAESTHETIC EYE DROPS
- Metabolic disorders agents
- Movement disorder agents
- MULTIPLE SCLEROSIS
- INTERFERONS
- MOTOR NEURONE DISEASE (MND)
- Muscle relaxants
- Neuromuscular blocking agents
- NON-DEPOLARISING BLOCKING AGENTS
- DEPOLARISING BLOCKING AGENTS
- Opioid analgesics
- Pregnancy, childbirth and breastfeeding
- AGENTS USED TO TREAT INFERTILITY
- AGENTS USED TO TREAT PRE-ECLAMPSIA AND ECLAMPSIA
- AGENTS USED TO MANAGE PREMATURE LABOUR
- AGENTS USED TO INDUCE LABOUR
- OXYTOCIC AGENTS
- AGENTS USED IN TERMINATION OF PREGNANCY
- LACTATION INHIBITORS
- Pulmonary hypertension agents
- Sedatives and hypnotics
- Sex hormones
- ANDROGENS AND ANABOLIC STEROIDS
- OESTROGENS
- PROGESTOGENS
- OTHER AGENTS
- COMBINED ORAL CONTRACEPTIVES (COC)
- Stimulants
- Sympathomimetic agents
- Thyroid and antithyroid agents
- THYROID AGENTS
- ANTITHYROID AGENTS
- Vaccines, immunoglobulins and antivenoms
- VACCINES
- ANTIVENOMS
- IMMUNOGLOBULINS
- Vasodilators
- Vitamins, minerals and electrolytes
- VITAMINS
- VITAMIN A
- VITAMIN B
- VITAMIN C
- VITAMIN D
- VITAMIN E
- VITAMIN K
- MINERAL SUPPLEMENTS
- CALCIUM
- IRON AND IRON COMPOUNDS
- MAGNESIUM
- OTHER MINERALS
- POTASSIUM
- BICARBONATE
- SODIUM
- ZINC
- AMINO ACIDS
- Miscellaneous agents
- Appendix 1 Poisoning and its treatment
- Appendix 2 Poisons information centres
- Appendix 3 Changes to drug names
- Bibliography
- Glossary
- Index
- Inside back cover
- Inside back cover
- No. of pages: 1774
- Language: English
- Edition: 11
- Published: October 18, 2021
- Imprint: Elsevier
- Paperback ISBN: 9780729543590
- eBook ISBN: 9780729588287
- eBook ISBN: 9780729588294
AT
Adriana Tiziani
Affiliations and expertise
Course Director, Postgraduate Studies in Wound Care, School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, VIC